Loading…
Kiora Pharmaceuticals, Inc. is projected to rise to $3.60 by 2027, a +29% move from its current price of $2.79. KPRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.71 | $2.79 | $2.88 | +0.09% |
| May 30 | $2.67 | $2.80 | $2.92 | +0.19% |
| May 31 | $2.65 | $2.80 | $2.95 | +0.28% |
| Jun 1 | $2.63 | $2.80 | $2.98 | +0.37% |
| Jun 2 | $2.61 | $2.80 | $3.01 | +0.47% |
| Jun 3 | $2.60 | $2.81 | $3.03 | +0.56% |
| Jun 4 | $2.59 | $2.81 | $3.05 | +0.65% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.59 | $2.81 | $3.05 | +0.65% |
| Week 2 | $2.51 | $2.83 | $3.18 | +1.31% |
| Week 3 | $2.47 | $2.85 | $3.28 | +1.98% |
| Week 4 | $2.43 | $2.86 | $3.38 | +2.64% |
| Week 5 | $2.40 | $2.88 | $3.47 | +3.32% |
| Week 6 | $2.37 | $2.90 | $3.55 | +3.99% |
| Week 7 | $2.35 | $2.92 | $3.63 | +4.67% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company focused on ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease.
The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has a strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301. The company operates in the United States, Austria, and Australia.
The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Kiora Pharmaceuticals is a small-cap healthcare company (healthcare category) trading under the ticker KPRX. It is currently priced at $2.79 with a market capitalization of $12.37M and a rank of 5041.
A major floor 32.6% below — a decisive break under it would weaken the trend.
The nearest floor, 16.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 11.2% above — clearing it would confirm fresh momentum.
Key KPRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KPRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.67 | Buy | $2.68 | Buy |
| MA 10 | $2.62 | Buy | $2.62 | Buy |
| MA 20 | $2.53 | Buy | $2.55 | Buy |
| MA 50 | $2.36 | Buy | $2.41 | Buy |
| MA 100 | $2.24 | Buy | $2.34 | Buy |
| MA 200 | $2.33 | Buy | $2.47 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.68 | Neutral |
| Stoch RSI (14) | 82.57 | Sell |
| CCI (20) | 185.26 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 13.88 | Buy |
| Bollinger %B (20,2) | 1.06 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.43 | Buy |
| Awesome (5,34) | 0.18 | Buy |
| Ultimate (7,14,28) | 70.63 | Sell |
| Momentum (10) | 0.35 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 2.72 | Buy |
| ADX (14) | 16.81 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture shows a bullish bias in sentiment. The RSI(14) is 60, with the 50-day simple moving average at $2.36 and the 200-day simple moving average at $2.33. Immediate support sits at $2.32 and resistance at $2.79.
Over the last 30 days, the price has traded between a low of $2.27 and a high of $3.43. The stock’s annualized volatility stands at 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.88 | $2.79 | $3.66 | 0% | Neutral | |
| $2.82 | $3.60 | $4.90 | +29% | Bullish | |
| $3.39 | $4.48 | $6.34 | +60% | Bullish | |
| $3.62 | $4.91 | $7.18 | +76% | Bullish | |
| $3.51 | $4.87 | $7.32 | +75% | Bullish | |
| $3.63 | $5.15 | $7.91 | +84% | Bullish | |
| $3.83 | $5.54 | $8.69 | +99% | Bullish | |
| $3.96 | $5.83 | $9.33 | +109% | Bullish | |
| $4.97 | $7.46 | $12.14 | +167% | Bullish | |
| $5.43 | $8.30 | $13.72 | +198% | Bullish | |
| $7.21 | $11.93 | $21.10 | +328% | Bullish | |
| $10.22 | $19.48 | $37.98 | +598% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.88 | $2.79 | $3.28 | +0.00% |
| June 2026 | $2.44 | $2.88 | $3.48 | +3.21% |
| July 2026 | $2.55 | $3.04 | $3.73 | +5.49% |
| August 2026 | $2.51 | $3.01 | $3.73 | -1.03% |
| September 2026 | $2.42 | $2.92 | $3.66 | -3.00% |
| October 2026 | $2.45 | $2.97 | $3.75 | +1.78% |
| November 2026 | $2.45 | $2.98 | $3.80 | +0.49% |
| December 2026 | $2.33 | $2.85 | $3.66 | -4.34% |
Click any year to see its month-by-month KPRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Kiora Pharmaceuticals, Inc.'s 2026 outlook centres on $2.79, within a $1.88 to $3.66 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, KPRX could reach as high as $4.90, with a base case around $3.60 and support toward $2.82 — roughly +29% from $2.79. Buyers look set to stay in control over this stretch.
Expect KPRX to range from $3.39 to $6.34 through 2028. The $4.48 average target implies a +60% move from current prices. That is up +24% on the projected 2027 average. Momentum favours further upside here.
The KPRX price prediction for 2029 points to an average of $4.91 (low $3.62, high $7.18) — a potential gain of +76% on today's $2.79. Buyers look set to stay in control over this stretch.
In 2030, KPRX is projected to trade between $3.51 and $7.32, averaging $4.87 — a potential gain of +75% from today's $2.79. That is -1% versus the projected 2029 average. Momentum favours further upside here.
Kiora Pharmaceuticals, Inc.'s 2031 outlook centres on $5.15, within a $3.63 to $7.91 range. That is up +6% on the projected 2030 average. That marks a +84% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, KPRX could reach as high as $8.69, with a base case around $5.54 and support toward $3.83 — roughly +99% from $2.79. Momentum favours further upside here.
Expect KPRX to range from $3.96 to $9.33 through 2033. The $5.83 average target implies a +109% move from current prices. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The KPRX price prediction for 2034 points to an average of $7.46 (low $4.97, high $12.14) — a potential gain of +167% on today's $2.79. Momentum favours further upside here.
In 2035, KPRX is projected to trade between $5.43 and $13.72, averaging $8.30 — a potential gain of +198% from today's $2.79. That is up +11% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Kiora Pharmaceuticals, Inc.'s 2040 outlook centres on $11.93, within a $7.21 to $21.10 range. That is up +44% on the projected 2035 average. That marks a +328% change versus current levels. Momentum favours further upside here.
By 2050, KPRX could reach as high as $37.98, with a base case around $19.48 and support toward $10.22 — roughly +598% from $2.79. Buyers look set to stay in control over this stretch.
Investing $1,000 in KPRX today (≈ 358.422939 KPRX) could be worth
$6,982.31
+$5,982.31 (+598%) by 2050 · US Dollar
Based on the average projected KPRX price of $19.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KPRXwould be worth at today's price.
$1,000 invested in KPRX on May 27, 2025 (≈ 337.837833 KPRX) would be worth
$942.57
-$57.43 (-5.7%) today · 0.94× · US Dollar
Based on a KPRX entry price of $2.96 vs. today's $2.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.64 | $1,056.82 | +5.7% |
| 1 month ago | $2.32 | $1,202.59 | +20.3% |
| 3 months ago | $2.1 | $1,328.57 | +32.9% |
| 6 months ago | $1.98 | $1,409.09 | +40.9% |
| 1 year ago | $2.96 | $942.57 | -5.7% |
| All time (5.0y) ago | $1,526.4 | $1.83 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KPRX forecast.
Our base-case forecast reaches $5.60 around 2033.
Implied market cap at $5.60: $24.82M
The multi-year forecast paints a steadily rising price path with bullish sentiment extending through 2032 and beyond. In 2027, the average price is forecast at $3.60 with a 29.2 ROI and bullish sentiment; in 2028 the average is $4.48 with a 60.5 ROI and bullish sentiment; in 2029 the average is $4.91 with a 76 ROI and bullish sentiment. By 2030, the average is $4.87 with a 74.7 ROI and bullish sentiment.
In 2040, the average is $11.93 with a 327.8 ROI and bullish sentiment, and by 2050 the average is $19.48 with a 598.2 ROI and bullish sentiment. The forecast shows continued bullish momentum into 2031–2035 (e.g., 2031 avg $5.15, 2032 avg $5.54, 2033 avg $5.83, 2034 avg $7.46, 2035 avg $8.30) and into the 2040s (2040 avg $11.93) before reaching the 2050 level. These are estimates and not guarantees; actual results depend on market conditions and execution of development plans.
Tap a question to reveal the answer.
2030 avg $4.87, min $3.51, max $7.32, ROI 74.7, sentiment BULLISH.
The forecast shows a bullish trajectory with rising averages and positive ROI across multiple years (e.g., 2027 avg $3.60 with ROI 29.2; 2028 avg $4.48 with ROI 60.5; 2029 avg $4.91 with ROI 76; 2030 avg $4.87 with ROI 74.7; 2050 avg $19.48 with ROI 598.2). These are estimates, not guarantees.
Yes. The forecast shows max prices of $13.72 in 2035, $21.10 in 2040, and $37.98 in 2050, indicating potential to exceed $10.
Current price $2.79; market cap $12.37M.
2050 avg $19.48; min $10.22; max $37.98; ROI 598.2; sentiment BULLISH.
Kiora Pharmaceuticals, Inc. Community Discussion
0Share your Kiora Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.